Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

The osteoclast is unique in its ability to resorb bone, and excessive osteoclastic activity has been implicated in osteoporosis, Paget disease of bone, rheumatoid arthritis, and the growth of metastases in bone. The activity of this cell is controlled by the main circulating inhibitor, calcitonin, i...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	MacIntyre, I, Zaidi, M, Alam, A S, Datta, H K, Moonga, B S, Lidbury, P S, Hecker, M, Vane, J R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1991
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC51355/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1849281/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.88.7.2936
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!